Market Dips: Palantir, Block, Vertiv, Nike, and Sony Face Challenges Amid Positive Developments

Generated by AI AgentAinvest Market Brief
Tuesday, Sep 3, 2024 6:00 pm ET1min read
PLTR--
1. Palantir Technologies (NYSE: PLTR)
Palantir Technologies dipped mildly by -2.55%. Palantir disclosed 22 insider trading transactions on August 22, 2024. Northland Capital Markets initiated coverage on Palantir with a market perform rating and a price target of $35.

2. Block (NYSE: SQ)
Block dipped mildly by -2.58%. Block reported Q2 2024 revenue of $12.113 billion, up 15.08% year-over-year, with net profit of $661 million. UBS maintains a buy rating on Block with a target price of $92. High-ranking executive Ahuja Amrita sold 6,661 shares on August 22, 2024.

3. Vertiv Holdings (NYSE: VRT)
Vertiv Holdings dipped mildly by -2.59%. Vertiv Holdings reported Q2 2024 revenue of $3.592 billion, up 10.34% year over year, and net profit of $172 million. Evercore ISI Group maintained its Outperform rating with a $105 target. Mizuho also upgraded Vertiv Holdings with a $92 target.

4. Nike (NYSE: NKE)
Nike dipped mildly by -2.62%. NIKE will hold its annual general meeting of shareholders on 2024-09-10. The company has announced a partnership with LEGO for new sports toys. Stifel maintains a hold rating on NIKE and lowers the price target to $79.00. Piper Sandler gives a neutral rating with an $80.00 price target.

5. Sony Group (NYSE: SONY)
Sony Group dipped mildly by -2.71%. Sony's PS5 Pro will feature enhanced ray tracing and rasterization performance similar to the AMD Radeon 7700XT GPU. Sony's game "Synapse" received mixed reviews with 864 comments. Sony Santa Monica is developing a new game, supporting 30 producers. Sony announced a 20% PS5 price increase.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet